YHLO Biotech

Company Deals

YHLO Biotech Partners with NCRCID to Develop Advanced Tuberculosis Diagnostics

Fineline Cube Mar 27, 2023

China-based Shenzhen YHLO Biotech Co., Ltd has entered into a strategic partnership with the National...

Company Deals

Shenzhen YHLO Biotech Partners with NCRCID for Advanced Tuberculosis Diagnostics

Fineline Cube Mar 27, 2023

China-based Shenzhen YHLO Biotech Co., Ltd has announced a strategic partnership with the National Clinical...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod